11.05.2008 Santen Announces Financial Result for the Second Quarter ended September 30, 2008

10.17.2008 Santen Announces Approval of TAPROS™ for Glaucoma and Ocular Hypertension Treatment in Japan

10.06.2008 Revision of Performance Forecast

10.03.2008 Santen to Launch Sante 40i OTC Eye Drop

08.04.2008 Santen Announces Financial Result for the First Quarter ended June 30, 2008

11.05.2008 Santen Announces Financial Result for the Second Quarter ended September 30, 2008

10.17.2008 Santen Announces Approval of TAPROS™ for Glaucoma and Ocular Hypertension Treatment in Japan

10.06.2008 Revision of Performance Forecast

08.04.2008 Santen Announces Financial Result for the First Quarter ended June 30, 2008

07.02.2008 Notice on the Exercise Price of Stock Options (Stock Acquisition Rights)